Skip to main content
SpringerLink
Log in

Advances in Management of Complications for Head and Neck Cancer Therapy

  • Chapter
  • First Online:
Head and Neck Cancer

Abstract

Increased use of the multimodality head and neck cancer (HNC) therapy has led to improvement in the local control, larynx preservation, and overall survival rates, leaving many HNC patients at risk for developing acute and late effects from treatment. The acute and late effects have resulted in substantial symptom burden and functional deficits in HNC population. The symptom control and functional issues associated with HNC and its aggressive treatment are complex, evolve over time, persist long term, and require frequent and ongoing assessment. In recent years, research efforts have focused on better understanding the supportive care needs in HNC patients across the trajectory of the disease treatment and recovery and developing new interventions to improve HNC patients’ overall quality of life. The aim of this chapter is to review symptom control issues in HNC, emphasizing areas in which interventions are feasible and have demonstrated improvement in patients’ outcome. Due to space limit, this chapter particularly focuses on the following areas: (1) nutrition and swallow function, (2) oral health, (3) acute and late musculoskeletal impairment (MSI), and (4) systemic effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 279.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Carlsson E, Ehrenberg A, Ehnfors M. Stroke and eating difficulties: long-term experiences. J Clin Nurs. 2004;13(7):825–34.

    Article  PubMed  Google Scholar 

  2. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199–212.

    Article  CAS  PubMed  Google Scholar 

  3. Ottosson S, Laurell G, Olsson C. The experience of food, eating and meals following radiotherapy for head and neck cancer: a qualitative study. J Clin Nurs. 2013;22(7-8):1034–43.

    Article  PubMed  Google Scholar 

  4. Ganzer H, Touger-Decker R, Parrott JS, Murphy BA, Epstein JB, Huhmann MB. Symptom burden in head and neck cancer: impact upon oral energy and protein intake. Support Care Cancer. 2013;21(2):495–503.

    Article  PubMed  Google Scholar 

  5. Silander E, Jacobsson I, Bertéus-Forslund H, Hammerlid E. Energy intake and sources of nutritional support in patients with head and neck cancer—a randomised longitudinal study. Eur J Clin Nutr. 2013;67(1):47–52.

    Article  CAS  PubMed  Google Scholar 

  6. van den Berg MG, Rütten H, Rasmussen-Conrad EL, et al. Nutritional status, food intake, and dysphagia in long-term survivors with head and neck cancer treated with chemoradiotherapy: a cross-sectional study. Head Neck. 2014;36(1):60–5.

    Article  PubMed  Google Scholar 

  7. Arthur AE, Peterson KE, Rozek LS, et al. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis. Am J Clin Nutr. 2013;97(2):360–8.

    Article  CAS  PubMed  Google Scholar 

  8. Orell-Kotikangas H, Schwab U, Österlund P, Saarilahti K, Mäkitie O, Mäkitie AA. High prevalence of vitamin D insufficiency in patients with head and neck cancer at diagnosis. Head Neck. 2012;34(10):1450–5.

    Article  PubMed  Google Scholar 

  9. da Cruz EP, Toporcov TN, Rotundo LD, et al. Food restrictions of patients who are undergoing treatment for oral and oropharyngeal cancer. Eur J Oncol Nurs. 2012;16(3):253–7.

    Article  Google Scholar 

  10. Britton B, Clover K, Bateman L, et al. Baseline depression predicts malnutrition in head and neck cancer patients undergoing radiotherapy. Support Care Cancer. 2012;20(2):335–42.

    Article  PubMed  Google Scholar 

  11. Kiss NK, Krishnasamy M, Loeliger J, Granados A, Dutu G, Corry J. A dietitian-led clinic for patients receiving (chemo) radiotherapy for head and neck cancer. Support Care Cancer. 2012;20(9):2111–20.

    Article  PubMed  Google Scholar 

  12. Sheth CH, Sharp S, Walters ER. Enteral feeding in head and neck cancer patients at a UK cancer centre. J Hum Nutr Diet. 2013;26(5):421–8.

    Article  CAS  PubMed  Google Scholar 

  13. Nugent B, Lewis S, O’Sullivan JM. Enteral feeding methods for nutritional management in patients with head and neck cancers being treated with radiotherapy and/or chemotherapy. Cochrane Database Syst Rev. 2013;1:CD007904.

    PubMed  Google Scholar 

  14. Langmore S, Krisciunas GP, Miloro KV, Evans SR, Cheng DM. Does PEG use cause dysphagia in head and neck cancer patients? Dysphagia. 2012;27(2):251–9.

    Article  PubMed  Google Scholar 

  15. Galloway TJ, Amdur RJ, Liu C, Yeung AR, Mendenhall WM. Revisiting unnecessary larynx irradiation with whole-neck IMRT. Pract Radiat Oncol. 2011;1(1):27–32.

    Article  PubMed  Google Scholar 

  16. Peponi E, Glanzmann C, Willi B, Huber G, Studer G. Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiat Oncol. 2011;6:1.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Cousins N, MacAulay F, Lang H, MacGillivray S, Wells M. A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol. 2013;49(5):387–400.

    Article  PubMed  Google Scholar 

  18. Zhen Y, Wang JG, Tao D, Wang HJ, Chen WL. Efficacy survey of swallowing function and quality of life in response to therapeutic intervention following rehabilitation treatment in dysphagic tongue cancer patients. Eur J Oncol Nurs. 2012;16(1):54–8.

    Article  PubMed  Google Scholar 

  19. Lang H, France E, Williams B, Humphris G, Wells M. The psychological experience of living with head and neck cancer: a systematic review and meta-synthesis. Psychooncology. 2013;22(12): 2648–63.

    Article  PubMed  Google Scholar 

  20. Robinson CA. Managing life with a chronic condition: the story of normalization. Qual Health Res. 1993;3(1):6–28.

    Article  CAS  PubMed  Google Scholar 

  21. Winkler MF, Wetle T, Smith C, Hagan E, O’Sullivan Maillet J, Touger-Decker R. The meaning of food and eating among home parenteral nutrition-dependent adults with intestinal failure: a qualitative inquiry. J Am Diet Assoc. 2010;110(11):1676–83.

    Article  PubMed  Google Scholar 

  22. Winkler MF. 2009 Lenna Frances Cooper Memorial Lecture: living with enteral and parenteral nutrition: how food and eating contribute to quality of life. J Am Diet Assoc. 2010;110(2):169–77.

    Article  PubMed  Google Scholar 

  23. Bisogni CA, Connors M, Devine CM, Sobal J. Who we are and how we eat: a qualitative study of identities in food choice. J Nutr Educ Behav. 2002;34(3):128–39.

    Article  PubMed  Google Scholar 

  24. McQuestion M, Fitch M, Howell D. The changed meaning of food: physical, social and emotional loss for patients having received radiation treatment for head and neck cancer. Eur J Oncol Nurs. 2011;15(2):145–51.

    Article  PubMed  Google Scholar 

  25. Röing M, Hirsch JM, Holmström I. The uncanny mouth—a phenomenological approach to oral cancer. Patient Educ Couns. 2007;67(3):301–6.

    Article  PubMed  Google Scholar 

  26. Semple CJ, Dunwoody L, George Kernohan W, McCaughan E, Sullivan K. Changes and challenges to patients’ lifestyle patterns following treatment for head and neck cancer. J Adv Nurs. 2008;63(1):85–93.

    Article  PubMed  Google Scholar 

  27. Mortensen GL, Paaske PB. Patients perceive tonsil cancer as a strike at psycho-socially “vital organs”. Dan Med J. 2012; 59(9):A4504.

    PubMed  Google Scholar 

  28. Swore Fletcher B, Cohen MZ, Schumacher K, Lydiatt W. A blessing and a curse: head and neck cancer survivors’ experiences. Cancer Nurs. 2012;35(2):126–32.

    Article  PubMed  Google Scholar 

  29. Larsson M, Hedelin B, Athlin E. Lived experiences of eating problems for patients with head and neck cancer during radiotherapy. J Clin Nurs. 2003;12(4):562–70.

    Article  PubMed  Google Scholar 

  30. Donovan M, Glackin M. The lived experience of patients receiving radiotherapy for head and neck cancer: a literature review. Int J Palliat Nurs. 2012;18(9):448–55.

    Article  PubMed  Google Scholar 

  31. Murphy B. Late treatment effects: reframing the questions. Lancet. 2009;10:530.

    Article  PubMed  Google Scholar 

  32. Murphy B, Ridner S, Wells N, Dietrich M. Quality of life research in head and neck cancer: a review of the current state of science. Crit Rev Oncol Hematol. 2007;62:251–67.

    Article  PubMed  Google Scholar 

  33. Deboni AL, Giordani AJ, Lopes NN, et al. Long-term oral effects in patients treated with radiochemotherapy for head and neck cancer. Support Care Cancer. 2012;20(11):2903–11.

    Article  PubMed  Google Scholar 

  34. Roh JL, Kim AY, Cho MJ. Xerostomia following radiotherapy of the head and neck affects vocal function. J Clin Oncol. 2005;23(13):3016–23.

    Article  PubMed  Google Scholar 

  35. Navazesh M, Wood GJ, Brightman VJ. Relationship between salivary flow rates and Candida albicans counts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1995;80(3):284–8.

    Article  CAS  PubMed  Google Scholar 

  36. Porter SR, Fedele S, Habbad KM. Xerostomia in head and neck malignancy. Oral Oncol. 2010;46(6):460–3.

    Article  CAS  PubMed  Google Scholar 

  37. Wagner W, Prott FJ, Schonekas KG. Amifostine: a radioprotector in locally advanced head and neck cancer. Oncol Rep. 1998;5(5): 1255–7.

    CAS  PubMed  Google Scholar 

  38. Rankin KV, Jones DL, Redding SW. Oral health in cancer therapy: a guide for health care professionals. file:///C:/Users/dengj/Desktop/MANU-MUST-New/working%20folder/Validation%20Article/Oral_Health_in_Cancer_Therapy_-_A_Guide_for_Health_Care_Professionals_3rd_edition.pdf. Accessed 1 Mar 2015.

    Google Scholar 

  39. Jha N, Seikaly H, Harris J, et al. Prevention of radiation induced xerostomia by surgical transfer of submandibular salivary gland into the submental space. Radiother Oncol. 2003;66(3):283–9.

    Article  PubMed  Google Scholar 

  40. Rieger J, Seikaly H, Jha N, et al. Submandibular gland transfer for prevention of xerostomia after radiation therapy: swallowing outcomes. Arch Otolaryngol Head Neck Surg. 2005;131(2):140–5.

    Article  PubMed  Google Scholar 

  41. Cassolato SF, Turnbull RS. Xerostomia: clinical aspects and treatment. Gerodontology. 2003;20(2):64–77.

    Article  PubMed  Google Scholar 

  42. Scarantino C, LeVeque F, Swann RS, et al. Effect of pilocarpine during radiation therapy: results of RTOG 97-09, a phase III randomized study in head and neck cancer patients. J Support Oncol. 2006;4(5):252–8.

    CAS  PubMed  Google Scholar 

  43. Chambers MS, Posner M, Jones CU, et al. Cevimeline for the treatment of postirradiation xerostomia in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2007;68(4):1102–9.

    Article  CAS  PubMed  Google Scholar 

  44. Simcock R, Fallowfield L, Monson K, et al. ARIX: a randomized trial of acupuncture v oral care sessions in patients with chronic xerostomia following treatment of head and neck cancer. Ann Oncol. 2013;24(3):776–83.

    Article  CAS  PubMed  Google Scholar 

  45. Meng Z, Garcia MK, Hu C, et al. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Cancer. 2012;118(13):3337–44.

    Article  PubMed  Google Scholar 

  46. Furness S, Bryan G, McMillan R, Birchenough S, Worthington HV. Interventions for the management of dry mouth: non-pharmacological interventions. Cochrane Database Syst Rev. 2013;9:CD009603.

    PubMed  Google Scholar 

  47. Towler P, Molassiotis A, Brearley SG. What is the evidence for the use of acupuncture as an intervention for symptom management in cancer supportive and palliative care: an integrative overview of reviews. Support Care Cancer. 2013;21(10):2913–23.

    Article  CAS  PubMed  Google Scholar 

  48. Schiødt M, Hermund NU. Management of oral disease prior to radiation therapy. Support Care Cancer. 2002;10(1):40–3.

    Article  PubMed  Google Scholar 

  49. Eliyas S, Al-Khayatt A, Porter RW, Briggs P. Dental extractions prior to radiotherapy to the jaws for reducing post-radiotherapy dental complications. Cochrane Database Syst Rev. 2013;2:CD008857.

    PubMed  Google Scholar 

  50. Epstein JB, Murphy BA. Late effects of cancer and cancer therapy on oral health and quality of life. J Mass Dent Soc. 2010;59(3):22–7.

    PubMed  Google Scholar 

  51. Fischer DJ, Epstein JB. Management of patients who have undergone head and neck cancer therapy. Dent Clin North Am. 2008;52(1):39–60, viii.

    Article  PubMed  Google Scholar 

  52. Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004;26(9):796–807.

    Article  PubMed  Google Scholar 

  53. Friedman PK, Isfeld D. Xerostomia: the “invisible” oral health condition. J Mass Dent Soc. 2008;57(3):42–4.

    PubMed  Google Scholar 

  54. Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer. 2005;13(1):32–41.

    Article  PubMed  Google Scholar 

  55. Husein AB, Butterworth CJ, Ranka MS, Kwasnicki A, Rogers SN. A survey of general dental practitioners in the North West of England concerning the dental care of patients following head and neck radiotherapy. Prim Dent Care. 2011;18(2):59–65.

    Article  PubMed  Google Scholar 

  56. Lyons A, Osher J, Warner E, Kumar R, Brennan PA. Osteoradionecrosis—a review of current concepts in defining the extent of the disease and a new classification proposal. Br J Oral Maxillofac Surg. 2014;52(5):392–5.

    Article  PubMed  Google Scholar 

  57. Marx RE, Johnson RP. Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64(4):379–90.

    Article  CAS  PubMed  Google Scholar 

  58. Lyons A, Ghazali N. Osteoradionecrosis of the jaws: current understanding of its pathophysiology and treatment. Br J Oral Maxillofac Surg. 2008;46(8):653–60.

    Article  PubMed  Google Scholar 

  59. Lyons AJ, West CM, Risk JM, et al. Osteoradionecrosis in head-and-neck cancer has a distinct genotype-dependent cause. Int J Radiat Oncol Biol Phys. 2012;82(4):1479–84.

    Article  PubMed  Google Scholar 

  60. Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer B Oral Oncol. 1996;32B(5):281–92.

    Article  CAS  PubMed  Google Scholar 

  61. Nguyen NP, Vock J, Chi A, et al. Effectiveness of intensity-modulated and image-guided radiotherapy to spare the mandible from excessive radiation. Oral Oncol. 2012;48(7):653–7.

    Article  PubMed  Google Scholar 

  62. Delanian S, Chatel C, Porcher R, Depondt J, Lefaix JL. Complete restoration of refractory mandibular osteoradionecrosis by prolonged treatment with a pentoxifylline-tocopherol-clodronate combination (PENTOCLO): a phase II trial. Int J Radiat Oncol Biol Phys. 2011;80(3):832–9.

    Article  PubMed  Google Scholar 

  63. Bennett MH, Feldmeier J, Hampson N, Smee R, Milross C. Hyperbaric oxygen therapy for late radiation tissue injury. Cochrane Database Syst Rev. 2012;16(5), CD005005.

    Google Scholar 

  64. Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncol. 2010;46(2):77–81.

    Article  PubMed  Google Scholar 

  65. Marunick MT, Seyedsadr M, Ahmad K, Klein B. The effect of head and neck cancer treatment on whole salivary flow. J Surg Oncol. 1991;48(2):81–6.

    Article  CAS  PubMed  Google Scholar 

  66. Nelson GM. Biology of taste buds and the clinical problem of taste loss. Anat Rec. 1998;253(3):70–8.

    Article  CAS  PubMed  Google Scholar 

  67. Nguyen HM, Reyland ME, Barlow LA. Mechanisms of taste bud cell loss after head and neck irradiation. J Neurosci. 2012;32(10):3474–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Fernando IN, Patel T, Billingham L, et al. The effect of head and neck irradiation on taste dysfunction: a prospective study. Clin Oncol. 1995;7(3):173–8.

    Article  CAS  Google Scholar 

  69. de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope. 2000;110(1):98–106.

    Article  PubMed  Google Scholar 

  70. Cooperstein E, Gilbert J, Epstein JB, et al. Vanderbilt head and neck symptom survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck. 2012;34(6):797–804.

    Article  PubMed  Google Scholar 

  71. Shi HB, Masuda M, Umezaki T, et al. Irradiation impairment of umami taste in patients with head and neck cancer. Auris Nasus Larynx. 2004;31(4):401–6.

    Article  PubMed  Google Scholar 

  72. Ripamonti C, Zecca E, Brunelli C, et al. A randomized, controlled clinical trial to evaluate the effects of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer. 1998;82(10):1938–45.

    Article  CAS  PubMed  Google Scholar 

  73. Halyard MY, Jatoi A, Sloan JA, et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007;67(5):1318–22.

    Article  CAS  PubMed  Google Scholar 

  74. Büntzel J, Glatzel M, Mücke R, Micke O, Bruns F. Influence of amifostine on late radiation-toxicity in head and neck cancer—a follow-up study. Anticancer Res. 2007;27(4A):1953–6.

    PubMed  Google Scholar 

  75. Jham BC, Chen H, Carvalho AL, Freire AR. A randomized phase III prospective trial of bethanechol to prevent mucositis, candidiasis, and taste loss in patients with head and neck cancer undergoing radiotherapy: a secondary analysis. J Oral Sci. 2009;51(4):565–72.

    Article  CAS  PubMed  Google Scholar 

  76. Epstein JB, Huhmann MB. Dietary and nutritional needs of patients after therapy for head and neck cancer. J Am Dent Assoc. 2012;143(6):588–92.

    Article  PubMed  Google Scholar 

  77. Cheville AL. Cancer rehabilitation. Semin Oncol. 2005;32(2):19–24.

    Article  Google Scholar 

  78. Bornbaum CC, Fung K, Franklin JH, Nichols A, Yoo J, Doyle PC. A descriptive analysis of the relationship between quality of life and distress in individuals with head and neck cancer. Support Care Cancer. 2012;20(9):2157–65.

    Article  PubMed  Google Scholar 

  79. McNeely M, Parliament M, Seikaly H, et al. Predictors of adherence to an exercise program for shoulder pain and dysfunction in head and neck cancer survivors. Support Care Cancer. 2012;20(3): 515–22.

    Article  PubMed  Google Scholar 

  80. Teymoortash A, Hoch S, Eivazi B, Werner JA. Postoperative morbidity after different types of selective neck dissection. Laryngoscope. 2010;120(5):924–9.

    PubMed  Google Scholar 

  81. Deng J. The impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Dissertation. Nashville: Vanderbilt University; 2010.

    Google Scholar 

  82. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004;40(9):879–89.

    Article  CAS  PubMed  Google Scholar 

  83. Hsiung CY, Huang EY, Ting HM, Huang HY. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol. 2008;81(970):809–14.

    Article  PubMed  Google Scholar 

  84. Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18(8):1033–8.

    Article  PubMed  Google Scholar 

  85. Stubblefield M, O’Dell M. Cancer rehabilitation: principles and practice. New York: Demos; 2009.

    Google Scholar 

  86. McNeely M, Parliament M, Seikaly H, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors. Cancer. 2008;113(1):214–22.

    Article  PubMed  Google Scholar 

  87. Nibu K, Ebihara Y, Ebihara M, et al. Quality of life after neck dissection: a multicenter longitudinal study by the Japanese Clinical Study Group on Standardization of Treatment for Lymph Node Metastasis of Head and Neck Cancer. Int J Clin Oncol. 2010;15(1):33–8.

    Article  PubMed  Google Scholar 

  88. Crevenna R, Maehr B, Fialka-Moser V, Keilani M. Strength of skeletal muscle and quality of life in patients suffering from “typical male” carcinomas. Support Care Cancer. 2009;17(10):1325–8.

    Article  PubMed  Google Scholar 

  89. Shih Y-CT XY, Cormier JN, et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a two-year follow-up study. J Clin Oncol. 2009;27:1–8.

    Article  Google Scholar 

  90. Horney DJ, Smith HE, McGurk M, et al. Associations between quality of life, coping styles, optimism, and anxiety and depression in pretreatment patients with head and neck cancer. Head Neck. 2011;33(1):65–71.

    Article  PubMed  Google Scholar 

  91. Murphy BA, Gilbert J, Ridner SH. Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther. 2007;7(7):1043–53.

    Article  PubMed  Google Scholar 

  92. Smith BG, Lewin JS. Lymphedema management in head and neck cancer. Curr Opin Otolaryngol Head Neck Surg. 2010;18(3): 153–8.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Carr SD, Bowyer D, Cox G. Upper limb dysfunction following selective neck dissection: a retrospective questionnaire study. Head Neck. 2009;31(6):789–92.

    Article  PubMed  Google Scholar 

  94. Lauchlan DT, McCaul JA, McCarron T, Patil S, McManners J, McGarva J. An exploratory trial of preventative rehabilitation on shoulder disability and quality of life in patients following neck dissection surgery. Eur J Cancer Care (Engl). 2011;20(1):113–22.

    Article  CAS  Google Scholar 

  95. Lauchlan DT, McCaul JA, McCarron T. Neck dissection and the clinical appearance of post-operative shoulder disability: the post-operative role of physiotherapy. Eur J Cancer Care (Engl). 2008;17(6):542–8.

    CAS  Google Scholar 

  96. Stuiver MM, van Wilgen CP, de Boer EM, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg. 2008;139(1):32–9.

    Article  PubMed  Google Scholar 

  97. van Wouwe M, de Bree R, Kuik DJ, et al. Shoulder morbidity after non-surgical treatment of the neck. Radiother Oncol. 2009;90(2):196–201.

    Article  PubMed  Google Scholar 

  98. Umeda M, Shigeta T, Takahashi H, et al. Shoulder mobility after spinal accessory nerve-sparing modified radical neck dissection in oral cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(6):820–4.

    Article  PubMed  Google Scholar 

  99. Deng J, Murphy BA, Dietrich MS, et al. The impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of life. Head Neck. 2013;35(7): 1026–35.

    Article  PubMed  Google Scholar 

  100. van Wilgen CP, Dijkstra PU, van der Laan BF, et al. Morbidity of the neck after head and neck cancer therapy. Head Neck. 2004;26(9):785–91.

    Article  PubMed  Google Scholar 

  101. Ahlberg A, Nikolaidis P, Engström T, et al. Morbidity of supraomohyoidal and modified radical neck dissection combined with radiotherapy for head and neck cancer: a prospective longitudinal study. Head Neck. 2012;34(1):66–72.

    Article  PubMed  Google Scholar 

  102. Hoebers F, Heemsbergen W, Moor S, et al. Reirradiation for head-and-neck cancer: delicate balance between effectiveness and toxicity. Int J Radiat Oncol Biol Phys. 2011;81(3):e111–8.

    Article  PubMed  Google Scholar 

  103. Montejo ME, Shrieve DC, Bentz BG, et al. IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2011;81(5):e845–52.

    Article  PubMed  Google Scholar 

  104. Melchers LJ, Van Weert E, Beurskens CHG, et al. Exercise adherence in patients with trismus due to head and neck oncology: a qualitative study into the use of the therabite. Int J Oral Maxillofac Surg. 2009;38(9):947–54.

    Article  CAS  PubMed  Google Scholar 

  105. Tsang KL, Fong KY, Ho SL, et al. Localized neuromyotonia of neck muscles after radiotherapy for nasopharyngeal carcinoma. Mov Disord. 1999;14(6):1047–9.

    Article  CAS  PubMed  Google Scholar 

  106. Terrell JE, Welsh DE, Bradford CR, et al. Pain, quality of life, and spinal accessory nerve status after neck dissection. Laryngoscope. 2000;110(4):620–6.

    Article  CAS  PubMed  Google Scholar 

  107. Laverick L, Lowe D, Brown JS, et al. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg. 2004;130(2):149–54.

    Article  PubMed  Google Scholar 

  108. Cheng PT, Hao SP, Lin YH, et al. Objective comparison of shoulder dysfunction after three neck dissection techniques. Ann Otol Rhinol Laryngol. 2000;109:761–6.

    Article  CAS  PubMed  Google Scholar 

  109. Inoue H, Nibu K, Saito A, et al. Quality of life after neck dissection. Arch Otolaryngol Head Neck Surg. 2006;132(6):662–6.

    Article  PubMed  Google Scholar 

  110. Kuntz AL, Weymuller EA. Impact of neck dissection on quality of life. Laryngoscope. 1999;109(8):1334–8.

    Article  CAS  PubMed  Google Scholar 

  111. Erisen L, Basel B, Irdesel J, et al. Shoulder function after accessory nerve-sparing neck dissections. Head Neck. 2004;26(11):967–71.

    Article  PubMed  Google Scholar 

  112. Sobol S, Jensen C, Sawyer W, et al. Objective comparison of physical dysfunction after neck dissection. Am J Surg. 1985;150(4):503–9.

    Article  CAS  PubMed  Google Scholar 

  113. van Wilgen CP. Morbidity after neck dissection in cancer. Dutch J Phys Ther. 2007;117:116–7.

    Google Scholar 

  114. Ülger Ö, Yağlı NV. Effects of yoga on balance and gait properties in women with musculoskeletal problems: a pilot study. Complement Ther Clin Pract. 2011;17(1):13–5.

    Article  PubMed  Google Scholar 

  115. Chen KM, Chen MH. Physical fitness of older adults in senior activity centres after 24-week silver yoga exercises. J Clin Nurs. 2008;17(19):2634–46.

    Article  PubMed  Google Scholar 

  116. Lennox AJ, Shafer JP, Hatcher M, Beil J, Funder SJ. Pilot study of impedance-controlled microcurrent therapy for managing radiation-induced fibrosis in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys. 2002;54(1):23–34.

    Article  PubMed  Google Scholar 

  117. Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial. J Clin Oncol. 2010;28(15):2565–70.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy of a dynamic jaw opening device (Dynasplint Trismus System) as part of the multimodal treatment of trismus in patients with head and neck cancer. Arch Phys Med Rehabil. 2010;91(8):1278–82.

    Article  PubMed  Google Scholar 

  119. Louise Kent M, Brennan MT, Noll JL, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008;16(3):305–9.

    Article  CAS  PubMed  Google Scholar 

  120. Silver HJ, Dietrich MS, Murphy BA. Changes in body mass, energy balance, physical function, and inflammatory state in patients with locally advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction chemotherapy. Head Neck. 2007;29(10):893–900.

    Article  PubMed  Google Scholar 

  121. Berger AM, Abernethy AP, Atkinson A, et al. Cancer-related fatigue. J Natl Compr Canc Netw. 2010;8(8):904–31.

    PubMed  Google Scholar 

  122. Spratt DE, Sakae M, Riaz N, et al. Time course and predictors for cancer-related fatigue in a series of oropharyngeal cancer patients treated with chemoradiation therapy. Oncologist. 2012;17(4): 569–76.

    Article  PubMed  PubMed Central  Google Scholar 

  123. Bansal M, Mohanti BK, Shah N, Chaudhry R, Bahadur S, Shukla NK. Radiation related morbidities and their impact on quality of life in head and neck cancer patients receiving radical radiotherapy. Qual Life Res. 2004;13(2):481–8.

    Article  CAS  PubMed  Google Scholar 

  124. Jereczek-Fossa BA, Santoro L, Alterio D, et al. Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007;68(2):403–15.

    Article  PubMed  Google Scholar 

  125. Mallinson T, Cella D, Cashy J, Holzner B. Giving meaning to measure: linking self-reported fatigue and function to performance of everyday activities. J Pain Symptom Manage. 2006;31(3):229–41.

    Article  PubMed  Google Scholar 

  126. Curt GA, Breitbart W, Cella D, et al. Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist. 2000;5(5):353–60.

    Article  CAS  PubMed  Google Scholar 

  127. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The Fatigue Coalition. Semin Hematol. 1997;34(3 suppl 2):4–12.

    CAS  PubMed  Google Scholar 

  128. Neuenschwander H, Bruera E, Cavalli F. Matching the clinical function and symptom status with the expectations of patients with advanced cancer, their families, and health care workers. Support Care Cancer. 1997;5(3):252–6.

    Article  CAS  PubMed  Google Scholar 

  129. Berger AM, Parker KP, Young-McCaughan S, et al. Sleep-wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum. 2005;32(6):98–126.

    Article  Google Scholar 

  130. Oldervoll LM, Loge JH, Lydersen S, et al. Physical exercise for cancer patients with advanced disease: a randomized controlled trial. Oncologist. 2011;16(11):1649–57.

    Article  PubMed  PubMed Central  Google Scholar 

  131. Sinard RJ, Tobin EJ, Mazzaferri EL, et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000;126(5):652–7.

    Article  CAS  PubMed  Google Scholar 

  132. Minton O, Richardson A, Sharpe M, Hotopf M, Stone PC. Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis. J Pain Symptom Manage. 2011;41(4):761–7.

    Article  CAS  PubMed  Google Scholar 

  133. Jean-Pierre P, Morrow GR, Roscoe JA, et al. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study. Cancer. 2010;116(14):3513–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Morrow GR, Hickok JT, Roscoe JA, et al. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol. 2003;21(24):4635–41.

    Article  CAS  PubMed  Google Scholar 

  135. Roscoe JA, Morrow GR, Hickok JT, et al. Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat. 2005;89(3):243–9.

    Article  CAS  PubMed  Google Scholar 

  136. Welsh LC, Dunlop AW, McGovern T, et al. Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin Oncol (R Coll Radiol). 2014;26(12):765–75.

    Article  CAS  Google Scholar 

  137. Bjordal K, Kaasa S. Psychological distress in head and neck cancer patients 7–11 years after curative treatment. Br J Cancer. 1995;71:592–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Lee PWH, Hung BKM, Woo EKW, et al. Effects of radiation therapy on neuropsychological functioning in patients with nasopharyngeal carcinoma. J Neurol Neurosurg Psychiatry. 1989;52: 488–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Woo E, Lam K, Yu YL, et al. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: a distinct clinical syndrome. J Neurol Neurosurg Psychiatry. 1988;51:1302–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  140. Meyers CA, Geara F, Wong PF, et al. Neurocognitive effects of therapeutic irradiation for base of skull tumors. Int J Radiat Oncol Biol Phys. 2000;46:51–5.

    Article  CAS  PubMed  Google Scholar 

  141. Hsiao KY, Yeh SA, Chang CC, et al. Cognitive function before and after intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: a prospective study. Int J Radiat Oncol Biol Phys. 2010;77:722–6.

    Article  PubMed  Google Scholar 

  142. Cheung MC, Chan AS, Law SC, et al. Cognitive function of patients with nasopharyngeal carcinoma with and without temporal lobe radionecrosis. Arch Neurol. 2000;57:1347–52.

    CAS  PubMed  Google Scholar 

  143. Lam LCW, Leung SF, Chan YL. Progress of memory function after radiation therapy in patients with nasopharyngeal carcinoma. J Neuropsychiatry Clin Neurosci. 2003;15:90–7.

    Article  PubMed  Google Scholar 

  144. Bond SM, Dietrich MS, Murphy BA. Neurocognitive function in head and neck cancer patients prior to treatment. Support Care Cancer. 2012;20(1):149–57.

    Article  PubMed  Google Scholar 

  145. Bond SM, Dietrich MS, Murphy BA. Patterns of self-reported neurocognitive deficits in head and neck cancer patients during concurrent chemoradiation. J Clin Oncol. 2010;28:e16015.

    Google Scholar 

  146. Bond SM, Hawkins DK, Murphy BA. Caregiver-reported neuropsychiatric symptoms in patients undergoing treatment for head and neck cancer: a pilot study. Cancer Nurs. 2014;37(3):227–35.

    Article  PubMed  PubMed Central  Google Scholar 

  147. Abayomi OK. Pathogenesis of cognitive decline following therapeutic irradiation for head and neck tumors. Acta Oncol. 2002;41:346–51.

    Article  PubMed  Google Scholar 

  148. Cheung MC, Chan AS, Law SC, et al. Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer. 2003;97:2019–26.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Vanderbilt University, 2220 Pierce Ave, 777 Preston Research Bldg, Nashville, TN, 37232, USA

    Barbara Murphy MD

  2. School of Nursing, Vanderbilt University, Nashville, TN, USA

    Jie Deng PhD, RN, OCN

  3. Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN, USA

    Mark J. Stavas MD

  4. Melbourne, FL, USA

    Heidi Ganzer DCN, RD, CSO, LD

  5. Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Joel B. Epstein DMD, MSD, FRCD(C), FDS RCS(E)

  6. Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, USA

    Joel B. Epstein DMD, MSD, FRCD(C), FDS RCS(E)

  7. Department of Surgery, City of Hope National Medical Center, Los Angeles, CA, USA

    Joel B. Epstein DMD, MSD, FRCD(C), FDS RCS(E)

Authors
  1. Barbara Murphy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jie Deng PhD, RN, OCN
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mark J. Stavas MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Heidi Ganzer DCN, RD, CSO, LD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Joel B. Epstein DMD, MSD, FRCD(C), FDS RCS(E)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara Murphy MD .

Editor information

Editors and Affiliations

  1. Department of Radio-Oncology, Genolier Swiss Medical Network, Genolier, Switzerland

    Jacques Bernier

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Murphy, B., Deng, J., Stavas, M.J., Ganzer, H., Epstein, J.B. (2016). Advances in Management of Complications for Head and Neck Cancer Therapy. In: Bernier, J. (eds) Head and Neck Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-27601-4_46

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-27601-4_46

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-27599-4

  • Online ISBN: 978-3-319-27601-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation